Spirilene

This classification denotes a dopamine antagonist with the molecular formula C24H28FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 672229USCQ, chemically known as 1,3,8-triazaspiro(4.5)decan-4-one, 8-(4-(p-fluorophenyl)-3-penenyl)-1-phenyl- but generally known as spirilene, which bears US NIH Compound Identifier 6436870. European Medicines Agency schedules Spirilene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10625MIG. The term SPIRILENE is an International Non-Proprietary Name. SPIRILENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule spirilene under HS 29333999 and SITC 51574. As of Q4 2014, SPIRILENE remains the US FDA Preferred Term for this commodity. Spirilene bears US NLM identifiers UMLS ID C0621228 and NCI Concept Code C90845. SMILES: FC1CCC(/C(=C\CCN2CCC3(N(CNC3=O)C3CCCCC3)CC2)C)CC1.